Home
News
Editorial
MD(e)B(unker)
Related Researches
Di Bella's Foundation
1960-1969
1970-1979
1980-1989
1990-1999
2000-2009
2010-2019
2020-2029
Science news
Scientific Documentation
About us...
Biography
Bibliography
The Method
Di Bella's Method!
1998 Trial!
Media
Video Publications
News-Papers
Press
Testimonial
Testimonies
Video Gallery
Congresses
Video Testimonies
TV & C.
Case History
Lung
Lymphomas
Non-Hodgkin Lymphomas
Hodgkin Lymphomas
Mediastinum
Mesothelioma
Myeloma
Pancreas
Scientific Publications
F.A.Q.
Useful Links
User Side
Vademecum
CouponChief - Resources for Cancer Patients
Contact Us
Home page
News
Related Researches
2010-2019
Title
Created Date
Protecting the melatonin rhythm through circadian healthy light exposure
23 April 2015
Oral administration of melatonin modulates the expression of tumor necrosis factor-α (TNF-α) gene in irradiated rat cervical spinal cord
21 April 2015
Melatonin: an inhibitor of breast cancer
21 April 2015
All-trans retinoic acid inhibits KIT activity and induces apoptosis in gastrointestinal stromal tumor GIST-T1 cell line by affecting on the expression of survivin and Bax protein
21 April 2015
Randomized phase II trial of All-trans-retinoic acid with chemotherapy based on paclitaxel and cisplatin as first-line treatment in patients with advanced non-small-cell lung cancer
20 April 2015
Octreotide acetate enables the administration of chemoradiotherapy, including the oral anticancer drug S-1, in gastric cancer patients with malignant gastrointestinal obstruction
17 April 2015
Phase I trial of 90Y-DOTATOC therapy in children and young adults with refractory solid tumors that express somatostatin receptors
08 April 2015
Melatonin, a novel Sirt1 inhibitor, imparts antiproliferative effects against prostate cancer in vitro in culture and in vivo in TRAMP model
07 April 2015
Absence of somatostatin SST(2) receptor internalization in vivo after intravenous SOM230 application in the AR42J animal tumor model
07 April 2015
Comparison of the Effects of 13-cis Retinoic Acid and Melatonin on the Viabilities of SH-SY5Y Neuroblastoma Cell Line
03 April 2015
Display #
5
10
15
20
25
30
50
100
All
Page 143 of 171
Start
Prev
138
139
140
141
142
143
144
145
146
147
Next
End
Search
Follow us...
Latest
Melatonin, an inhibitory agent in breast cancer
Melatonin: an inhibitor of breast cancer
Therapeutic treatments potentially mediated by melatonin receptors: potential clinical uses in the prevention of osteoporosis, cancer and as an adjuvant therapy
Differential expression of high-affinity melatonin receptors (MT1) in normal and malignant human breast tissue
In Vitro Investigations on the Antioxidant Effects of Vitamin D in a Panel of Cancer Cell Lines
Melatonin Inhibits Gastric Cancer Cell Proliferation by Suppressing Exosome miR-27b-3p Expression
Vitamin D deficiency as a risk factor for thyroid cancer: A meta-analysis of case-control studies
Melatonin and its therapeutic prospects in gastroenterology
Catecholamines Mediate Psychologic Stress-Induced Cancer Progression
Psychologic Stress Drives Progression of Malignant Tumors via DRD2/HIF1α Signaling
Melatonin Alleviates Acute Respiratory Distress Syndrome by Inhibiting Alveolar Macrophage NLRP3 Inflammasomes Through the ROS/HIF-1α/GLUT1 Pathway
The potential therapeutic effect of melatonin on human ovarian cancer by inhibition of invasion and migration of cancer stem cells
Melatonin Supplementation Improves Pain, Sleep Quality, and Total Plasma Antioxidant Capacity in Women with Fibrocystic Breast Disease: A Randomized, Double-blind, Placebo-controlled Trial
Melatonin as antioxidant, geroprotector and anticarcinogen
Pretreatment with melatonin protects against cyclophosphamide-induced oxidative stress and renal damage in mice
The role of calcium and vitamin D dietary intake on risk of colorectal cancer: systematic review and meta-analysis of case-control studies
SSTR2-targeting therapy in EBV-positive and EBV-negative metastatic nasopharyngeal carcinoma
Melatonin Represses Metastasis in Her2-Postive Human Breast Cancer Cells by Suppressing RSK2 Expression
Most Read
The Di Bella Method (DBM)
About melatonin - 1996
All-trans-retinoic acid and cancer
Biography
The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
Somatostatin in oncology, the overlooked evidences
Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
How effective is chemo therapy?
Bibliography
Complete objective response to biological therapy of plurifocal breast carcinoma
Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
Vademecum
Frequently Asked Questions
Declaration recommends eliminate the use of Impact factor for research evaluation
Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer